TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.
TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.
复制标题
DOI:
10.1523/jneurosci.5894-09.2010
复制
发表时间:
2010-06-02
期刊:
影响因子:
--
通讯作者:
Taylor JP
中科院分区:
文献类型:
--
作者:
Ritson GP;Custer SK;Freibaum BD;Guinto JB;Geffel D;Moore J;Tang W;Winton MJ;Neumann M;Trojanowski JQ;Lee VM;Forman MS;Taylor JP
Inclusion body myopathy associated with Paget’s disease of bone and frontotemporal dementia (IBMPFD) is a dominantly inherited degenerative disorder caused by mutations in the valosin-containing protein (VCP) gene. VCP (p97 in mouse, TER94 in D. melanogaster, and CDC48 in S. cerevisiae) is a highly conserved AAA+-ATPase that regulates a wide array of cellular processes. The mechanism of IBMPFD pathogenesis is unknown. To elucidate the pathogenic mechanism, we developed and characterized a Drosophila model of IBMPFD (mutant VCP–related degeneration). Based on genetic screening of this model we identified three RNA-binding proteins that dominantly suppressed degeneration; one of these was TBPH, the Drosophila homolog of TAR DNA-binding protein (TDP-43). Here we demonstrate that VCP and TDP-43 interact genetically and that disease-causing mutations in VCP lead to redistribution of TDP-43 to the cytoplasm in vitro and in vivo, replicating the major pathology observed in IBMPFD and other TDP-43 proteinopathies. We also demonstrate that TDP-43 redistribution from the nucleus to the cytoplasm is sufficient to induce cytotoxicity. Furthermore, we determined that a pathogenic mutation in TDP-43 promotes redistribution to the cytoplasm and enhances the genetic interaction with VCP. Taken together, our results show that degeneration associated with VCP mutations is mediated in part by toxic gain-of-function of TDP-43 in the cytoplasm. We suggest that these findings are likely relevant to the pathogenic mechanism of a broad array of TDP-43 proteinopathies, including frontotemporal lobar degeneration and amyotrophic lateral sclerosis.